Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes

T1D Exchange, United States · NCT06931275

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 2–95 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
1178
US sites recruiting
1
Study start
August 13, 2024
Record last updated
April 17, 2025

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The overall goal of the study is to create a standardized, stakeholder-informed system within EMRs, that will enable an equitable and regular prescription and documentation of advanced diabetes technologies. This will reduce racial disparities and generate an understanding of the reasons behind prescription decisions.

The study will highlight the development and implementation an EMR-based Best Practice Advisory (BPA).

The study will answer whether the EMR-based BPA can effectively reduce disparities. Additionally, it will explore why providers may not prescribe advanced diabetes technologies.

Patients will also be surveyed to understand their perspectives on developing the EMR-based BPA.

Being studied: EMR-based BPA model; Placebo (EMR-based without BPA model)

Conditions: Diabetes Mellitus, Type 1

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Age ≥ 2 years with an EMR diagnosis of T1D for at least 6 months at baseline and receiving care at one of six intervention centers or a matched control at another T1DX-QI center.

Inclusion Criteria

  • non-Hispanic Black and Hispanic individuals

Exclusion Criteria

  • PwT1D with evidence of use of AID at baseline

Recruiting US locations

  • T1D Exchange

    Boston, MA 02110

    Site contact: Osagie Ebekozien, MPH, MD · 857-205-2388 · oebekozien@t1dexchange.org

Study contacts (from the official record)

  • Osagie Ebekozien, MD · 857-205-2388 · oebekozein@t1dexchange.org
  • Trevon Wright, MHA · 6178927564 · twright@t1dexchange.org
All diabetes studies in Massachusetts →
Best Practice Advisories to Reduce Inequities in Technology Use… (NCT06931275) | Bored Studies